Taking Risks with Translational Research-Reference-Cited by-同舟云学术

Taking Risks with Translational Research

Published:2010-03-24 Issue:24 Volume:2 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Mills Ian G.¹,Sykes Richard B.²

Affiliation:

1. Uro-Oncology Research Group, Cancer Research UK Cambridge, Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Norwegian Centre for Molecular Medicine, Nordic EMBL Partnership, University of Oslo, Blindern N-0317 Oslo, Norway.

2. NHS London, Southside, 105 Victoria Street, London SW1E 6QT, UK.

Abstract

The private sector should undertake the high-throughput elements of translational research, while the public sector funds the development of scientists with the confidence to attempt to translate genetic data into a mechanistic understanding of complex diseases.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. Are Epigeneticists Ready for Big Science?

2. Decoding Iceland: The next big medical breakthroughs may result from one scientist’s battle to map the Viking gene pool.;Specter M.;New Yorker,1999

3. Clinton and Blair Back Rapid Release of Data

4. Cash-Starved deCODE Is Looking For a Rescuer for Its Biobank

5. K. Stefánsson Icelandic genetic database not at risk from bankruptcy. Nature 463 25 (2010).Medline

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Subtyping of Prostate Cancer: A Partnership Model;European Urology;2015-10

2. Translational Research: From Biological Discovery to Public Benefit (or Not);Advances in Biology;2014-06-30

3. Complexity in Common Diseases: Big Biology for All;Science Translational Medicine;2010-03-31